ArticleP & T : a peer-reviewed journal for formulary management2012

Roflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease.

Jordan BayePubMed ↗Full text ↗

No numbers read from the abstract.